Skip to main content

Table 1 Patient characteristics

From: Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm3)

Age (yrs) Percent patients (n = 57)
  <60 7
  60-69 45.6
  70-79 35.1
  ≥80 12.3
Race
  White 54.4
  Black 40.4
  Other 5.3
Pre-treatment PSA (ng/ml)
  ≤10 77.2
  10 < PSA ≤ 20 15.8
  >20 7
T-Stage
  T1c 73.7
  T2a 12.3
  T2b 12.3
  T2c 1.8
Gleason score
  5 1.8
  6 44
  7 42
  8 10.4
  Other 1.8
Risk group  
  Low risk 40.4
  Intermediate risk 43.9
  High risk 15.7
Hormone treatment  
  Yes 33
  No 67
Dose
  35 Gy 19.3
  35.25 Gy 1.8
  36.25 Gy 78.9
α 1A Inhibitor (Flomax)  
  Yes 37
  No 63